Trial · NCT04287777
Safety and Efficacy of Mupirocin Gel in Children With Impetigo
NCT04287777, Phase 3, Completed, Reig Jofre Group
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Safety and Efficacy of Mupirocin Gel in Children With Impetigo. Trials, record NCT04287777. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04287777
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Safety and Efficacy of Mupirocin Gel in Children With Impetigo
- NCT number
- NCT04287777
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 467 participants, actual
- Lead sponsor
- Reig Jofre Group
- Conditions
- Impetigo
- Interventions
- Mupirocin gel, Mupirocin ointment, Placebo
- First posted
- 2020-02-27
- Last updated
- 2021-03-12
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Clinical cure at the end of treatment by SIRS assessed by blind observer | Day 8 | Proportion of subjects with clinical cure at the Day 8 visit, assessed by blind observer, according to criteria described in the Protocol (SIRS \< or = 2). |
| Primary | Clinical cure as assessed by the proportion of subjects with no additional antibiotic therapy required to treat impetigo at day 8 | Day 8 | proportion of subjects with no additional antibiotic therapy required to treat impetigo |
| Secondary | Clinical cure at the end of follow up by SIRS assessed by blind observer | Day14 | Proportion of subjects with clinical cure at the Day 14 visit, assessed by blind observer, according to criteria described in the protocol (SIRS \< or = 2). |
| Secondary | Clinical cure as assessed by the proportion of subjects with no additional antibiotic therapy required to treat impetigo at day 14 | Day14 | proportion of subjects with no additional antibiotic therapy required to treat impetigo |
| Secondary | Total SIRS score at the end of treatment and follow-up by blind observer | Day 8 and 14 | |
| Secondary | Bacteriology cure at follow-up | Day 14 | Bacteriology eradication at the end of follow-up period according to culture at screening and follow up visits |
| Secondary | Clinical cure at the end of treatment and follow-up by investigator | Day 8 and 14 | Proportion of subjects with clinical cure at the Day 8 and Day 14 visits, assessed by investigator, according to protocol criteria. |
| Secondary | SIRS total score at the end of treatment and follow-up by investigator | Day 8 and 14 | SIRS total Score at Day 8 and Day 14 visits, assessed by the investigator |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04287777
GET https://conductscience.org/api/trials/v1/NCT04287777/registered